Related Experiment Videos
Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2020
Lessons learned from 227 biological meshes used for the surgical treatment of ventral abdominal defects.
Hernia : the journal of hernias and abdominal wall surgery·2019
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.
European journal of cancer (Oxford, England : 1990)·2026
Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.
European journal of cancer (Oxford, England : 1990)·2026
Genomic landscape of sweat gland carcinomas: Clinical applications and future directions.
European journal of cancer (Oxford, England : 1990)·2026
Organ-preserving surgery for solid pseudopapillary neoplasm of the pancreas: A multicentric study.
European journal of cancer (Oxford, England : 1990)·2026
Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.
European journal of cancer (Oxford, England : 1990)·2026
Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase II study (GeNeS1S trial).
European journal of cancer (Oxford, England : 1990)·2026